Varlas Valentin Nicolae, Bohîlțea Laurențiu-Camil, Suciu Nicolae
Department of Obstetrics and Gynecology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Department of Obstetrics and Gynecology, Filantropia Clinical Hospital, 011132 Bucharest, Romania.
Nutrients. 2025 Apr 30;17(9):1535. doi: 10.3390/nu17091535.
BACKGROUND/OBJECTIVES: In recent years, due to the emergence of antimicrobial resistance, probiotics have been increasingly used during pregnancy and lactation with real maternal-fetal benefits. Probiotic intervention, especially multi-strain probiotics, due to their anti-inflammatory, metabolic, and immunomodulatory actions, can be performed prophylactically and therapeutically with promising results regarding maternal, fetal, and neonatal health. The administration of probiotics can modulate the maternal microbiome, regulate microflora imbalance in various conditions (overweight/obesity, gestational diabetes mellitus (GDM), preeclampsia, allergic diseases), and influence several reactions such as modulating the non-specific cellular immune system, metabolic processes, and inhibition of pathogens. This study aimed to analyze, based on available data, how the administration of probiotic supplements to women during pregnancy can modify immunometabolic responses to microbial dysbiosis to limit weight gain and the risk of obesity, to improve glucose homeostasis and reduce the risk of GDM, to prevent preeclampsia and its effects on maternal-fetal outcomes, and to reduce rates of atopic eczema and allergic diseases in infants.
We performed a systematic search in MEDLINE/PubMed to identify studies that have investigated the effects of probiotic intervention on the immunometabolic response in pregnancy and lactation, especially in women with diabetes, overweight/obesity, preeclampsia, and allergic conditions.
Fifty-six RCT studies, totaling 15,044 women, matched the inclusion criteria, of which eight were for interventions on the immune response, twenty on allergic conditions, seven on obesity and excess weight gain in pregnancy, and twenty-one on GDM.
Due to the heterogeneous structure and the size of the samples, the methodologies, formulations, moment of initiation, and study durations, future research is needed to establish their effectiveness and safety in pregnancy and lactation regarding maternal-fetal health and outcomes in childhood and adult life.
背景/目的:近年来,由于抗菌药物耐药性的出现,益生菌在孕期和哺乳期的使用日益增多,并确实对母婴有益。益生菌干预,尤其是多菌株益生菌,因其具有抗炎、代谢和免疫调节作用,可用于预防和治疗,有望改善母婴及新生儿健康。服用益生菌可调节孕妇微生物群,调节各种情况下(超重/肥胖、妊娠期糖尿病(GDM)、先兆子痫、过敏性疾病)的菌群失衡,并影响多种反应,如调节非特异性细胞免疫系统、代谢过程以及抑制病原体。本研究旨在基于现有数据分析,孕期女性服用益生菌补充剂如何改变对微生物群失调的免疫代谢反应,以限制体重增加和肥胖风险,改善葡萄糖稳态并降低GDM风险,预防先兆子痫及其对母婴结局的影响,以及降低婴儿特应性皮炎和过敏性疾病的发生率。
我们在MEDLINE/PubMed中进行了系统检索,以确定研究益生菌干预对妊娠和哺乳期免疫代谢反应影响的研究,尤其是对患有糖尿病、超重/肥胖、先兆子痫和过敏性疾病的女性的影响。
56项随机对照试验研究,共计15044名女性,符合纳入标准,其中8项是关于免疫反应干预的,20项是关于过敏性疾病的,7项是关于妊娠期间肥胖和体重过度增加的,21项是关于GDM的。
由于样本的结构、大小、方法、制剂、起始时间和研究持续时间存在异质性,未来需要开展研究,以确定其在孕期和哺乳期对母婴健康以及儿童和成人期结局的有效性和安全性。